Merck KGaA (MRK.DE)
Healthcare • Drug Manufacturers - Specialty & Generic
StockXETRAGermanyDE0006599905
148.90 EUR
+0.51% today Updated 13 Nov 2026 09:38
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Merck KGaA, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in EUR. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 09:38. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
—No date announced yet
Last results
2.32 vs 2.20 estimated
11 Nov 2026 · Beat +5.6%
Beat the estimate
7 of 12
4 missed · 1 in line · 2 beats in a row
Average surprise
+2.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Nov 2026 19:00 | 2.20 | 2.32 | +5.6% | Beat |
| 06 Aug 2026 03:00 | 2.05 | 2.16 | +5.3% | Beat |
| 05 Mar 2026 01:00 | 1.94 | 1.88 | -3.1% | Miss |
| 13 Nov 2025 02:00 | 2.20 | 2.32 | +5.6% | Beat |
| 07 Aug 2025 01:00 | 2.14 | 2.02 | -5.5% | Miss |
| 15 May 2025 01:00 | 2.16 | 2.12 | -2.0% | Miss |
| 06 Mar 2025 01:00 | 2.19 | 2.07 | -5.4% | Miss |
| 13 Nov 2024 20:00 | 2.27 | 2.30 | +1.3% | Beat |
| 31 Jul 2024 22:00 | 1.91 | 2.20 | +15.4% | Beat |
| 14 May 2024 22:00 | 1.94 | 2.06 | +6.0% | Beat |
| 06 Mar 2024 20:00 | 1.85 | 1.86 | +0.3% | In line |
| 09 Nov 2023 01:00 | 1.93 | 2.07 | +7.5% | Beat |
| 03 Aug 2023 01:00 | 2.18 | 2.20 | +1.1% | Beat |
| 11 May 2023 01:00 | 2.28 | 2.36 | +3.4% | Beat |
| 02 Mar 2023 | 2.49 | 2.32 | -6.7% | Miss |
| 10 Nov 2022 01:00 | 2.64 | 2.68 | +1.3% | Beat |
| 04 Aug 2022 01:00 | 2.52 | 2.64 | +4.8% | Beat |
| 12 May 2022 01:00 | 2.35 | 2.41 | +2.5% | Beat |
| 02 Mar 2022 20:00 | 2.06 | 2.06 | -0.2% | In line |
| 10 Nov 2021 20:00 | 2.20 | 2.24 | +2.0% | Beat |
| 04 Aug 2021 22:00 | 2.07 | 2.24 | +8.3% | Beat |
| 11 May 2021 22:00 | 1.72 | 2.18 | +26.4% | Beat |
| 03 Mar 2021 20:00 | 1.58 | 1.57 | -0.4% | In line |
| 12 Nov 2020 02:00 | 2.22 | 2.34 | +5.6% | Beat |
| 06 Aug 2020 09:00 | 1.33 | 1.30 | -2.3% | Miss |
| 13 May 2020 22:00 | 1.43 | 1.50 | +5.1% | Beat |
| 04 Mar 2020 20:00 | 1.54 | 1.54 | +0.2% | In line |
| 14 Nov 2019 01:00 | 1.40 | 1.35 | -3.5% | Miss |
| 08 Aug 2019 01:00 | 1.49 | 1.54 | +3.2% | Beat |
| 14 May 2019 01:00 | 1.24 | 1.13 | -9.1% | Miss |
| 07 Mar 2019 01:00 | 1.33 | 1.22 | -8.4% | Miss |
| 13 Nov 2018 20:00 | 1.26 | 1.32 | +4.5% | Beat |
| 09 Aug 2018 01:00 | 1.30 | 1.23 | -5.1% | Miss |
| 15 May 2018 01:00 | 1.38 | 1.41 | +2.5% | Beat |
| 08 Mar 2018 01:00 | 1.35 | 1.31 | -2.8% | Miss |
| 09 Nov 2017 01:00 | 1.48 | 1.51 | +2.0% | Beat |
| 03 Aug 2017 01:00 | 1.55 | 1.54 | -0.6% | In line |
| 18 May 2017 01:00 | 1.72 | 1.80 | +4.6% | Beat |
| 09 Mar 2017 01:00 | 1.51 | 1.43 | -5.5% | Miss |
| 15 Nov 2016 01:00 | 1.56 | 1.70 | +8.8% | Beat |
| 04 Aug 2016 01:00 | 1.53 | 1.55 | +1.3% | Beat |
| 19 May 2016 01:00 | 1.42 | 1.54 | +8.7% | Beat |
| 08 Mar 2016 01:00 | 1.16 | 1.13 | -3.0% | Miss |
| 12 Nov 2015 01:00 | 1.21 | 1.32 | +8.8% | Beat |
| 06 Aug 2015 01:00 | 1.20 | 1.30 | +8.4% | Beat |
| 19 May 2015 01:00 | 1.14 | 1.12 | -1.5% | Miss |
| 03 Mar 2015 01:00 | 1.14 | 1.14 | +0.0% | In line |
| 13 Nov 2014 01:00 | 1.17 | 1.15 | -1.3% | Miss |
| 13 Aug 2014 13:00 | 1.17 | 1.16 | -1.0% | Miss |
| 15 May 2014 09:00 | 1.11 | 1.16 | +3.9% | Beat |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 21.1B | -0.3% | 2.6B | 12.4% | 6.00 | -6.1% | 2B |
| 2024 | 21.2B | +0.8% | 2.8B | 13.1% | 6.39 | -1.5% | 2.4B |
| 2023 | 21B | -5.6% | 2.8B | 13.5% | 6.49 | -15.2% | 1.8B |
| 2022 | 22.2B | — | 3.3B | 15.0% | 7.65 | — | 2.5B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 150.15 | 156.25 | 144.00 | 148.90 | -1.59% | 2,862,790 | |
| Oct 2026 | 137.00 | 152.10 | 132.95 | 151.30 | +9.56% | 5,808,195 | |
| Sep 2026 | 143.25 | 143.45 | 129.15 | 138.10 | -0.65% | 6,577,200 | |
| Aug 2026 | 143.95 | 148.80 | 134.95 | 139.00 | -2.90% | 4,940,299 | |
| Jul 2026 | 146.95 | 148.65 | 130.10 | 143.15 | -2.52% | 5,898,564 | |
| Jun 2026 | 130.00 | 147.85 | 128.85 | 146.85 | +12.23% | 8,942,112 | |
| May 2026 | 109.75 | 131.85 | 108.25 | 130.85 | +18.90% | 7,078,385 | |
| Apr 2026 | 110.45 | 121.25 | 106.55 | 110.05 | +2.28% | 7,050,191 | 2.2000 |
| Mar 2026 | 124.40 | 126.50 | 100.70 | 107.60 | -16.13% | 9,526,517 | |
| Feb 2026 | 125.65 | 129.30 | 119.85 | 128.30 | +2.19% | 5,498,224 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in EUR, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances (opens in a new tab) Zacks · 09 Nov 2026 12:50
- Earnings Preview: Merck KGaA (MKKGY) Q3 Earnings Expected to Decline (opens in a new tab) Zacks · 05 Nov 2026 14:00
- Bio-Techne (TECH), What Is Behind The Fresh Attention Now? (opens in a new tab) Simply Wall St. · 04 Nov 2026 19:10
- Lonza to acquire five US manufacturing sites from Merck KGaA (opens in a new tab) Pharmaceutical Technology · 03 Nov 2026 10:59
- Merck KGaA (XTRA:MRK) Stock Seems Hard To Call After Its 30% Run (opens in a new tab) Simply Wall St. · 20 Oct 2026 19:16
- Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics (opens in a new tab) Pharmaceutical Technology · 20 Oct 2026 12:28
- Is Merck KGaA (XTRA:MRK) Undervalued On Silence Therapeutics Deal News? (opens in a new tab) Simply Wall St. · 20 Oct 2026 05:27
- Merck KGaA (XTRA:MRK) Makes A Rare Disease Bet With A Phase 3 Ready siRNA Deal (opens in a new tab) Simply Wall St. · 20 Oct 2026 02:16
- Silence Therapeutics (SLN) Gets 130% Premium Offer From Merck, Shares Surge Over 100% (opens in a new tab) Insider Monkey · 20 Oct 2026 00:41
- Silence Therapeutics to Be Acquired by Germany's Merck in $1.3 Billion Deal; Shares Surge (opens in a new tab) MT Newswires · 19 Oct 2026 20:30
- Merck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125% (opens in a new tab) Barrons.com · 19 Oct 2026 17:08
- Silence Therapeutics Soars 125% on All-Cash $1.3 Billion Merck KGaA Buyout: “Immediate and Certain” (opens in a new tab) TIKR · 19 Oct 2026 16:49
- Silence Therapeutics Agrees to $1.3 Billion Merck KGaA Acquisition at 130% Premium (opens in a new tab) InvestorsHub · 19 Oct 2026 16:23
- Silence Therapeutics jumps 59% on Merck takeover (opens in a new tab) Proactive · 19 Oct 2026 16:20
- Merck KGaA bets on RNAi with $1.3B Silence buyout (opens in a new tab) BioPharma Dive · 19 Oct 2026 14:59
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 148.15 EUR
- Market cap
- 64.7B
- Dividend yield
- 1.48%
- 5-year average yield
- 1.31%
- Payout ratio
- 40%
- Last dividend
- 2.2000 EUR · 27 Apr 2026
- Exchange
- XETRA
- Country
- Germany
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- EUR
Dividends
| Ex-dividend date | Per share |
|---|---|
| 27 Apr 2026 | 2.2000 EUR |
| 28 Apr 2025 | 2.2000 EUR |
| 29 Apr 2024 | 2.2000 EUR |
| 02 May 2023 | 2.2000 EUR |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow MRK.DE and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.